Skip to main content
Top
Published in: Emerging Themes in Epidemiology 1/2006

Open Access 01-12-2006 | Methodology

Identifying related cancer types based on their incidence among people with multiple cancers

Authors: Chris D Bajdik, Zenaida U Abanto, John J Spinelli, Angela Brooks-Wilson, Richard P Gallagher

Published in: Emerging Themes in Epidemiology | Issue 1/2006

Login to get access

Abstract

Background

There are several reasons that someone might be diagnosed with more than one primary cancer. The aim of this analysis was to determine combinations of cancer types that occur more often than expected. The expected values in previous analyses are based on age-and-gender-adjusted risks in the population. However, if cancer in people with multiple primaries is somehow different than cancer in people with a single primary, then the expected numbers should not be based on all diagnoses in the population.

Methods

In people with two or more cancer types, the probability that a specific type is diagnosed was determined as the number of diagnoses for that cancer type divided by the total number of cancer diagnoses. If two types of cancer occur independently of one another, then the probability that someone will develop both cancers by chance is the product of the individual probabilities for each type. The expected number of people with both cancers is the number of people at risk multiplied by the separate probabilities for each cancer. We performed the analysis on records of cancer diagnoses in British Columbia, Canada between 1970 and 2004.

Results

There were 28,159 people with records of multiple primary cancers between 1970 and 2004, including 1,492 people with between three and seven diagnoses. Among both men and women, the combinations of esophageal cancer with melanoma, and kidney cancer with oral cancer, are observed more than twice as often as expected.

Conclusion

Our analysis suggests there are several pairs of primary cancers that might be related by a shared etiological factor. We think that our method is more appropriate than others when multiple diagnoses of primary cancer are unlikely to be the result of therapeutic or diagnostic procedures.
Appendix
Available only for authorised users
Literature
1.
go back to reference Travis LB, Hill DA, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Wiklund T, Lynch CF, Van't Veer MB, Glimelius I, Storm H, Pukkala E, Stovall M, Curtis R, Boice JD Jr, Gilbert E: Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA. 2003, 290: 465-75. 10.1001/jama.290.4.465CrossRefPubMed Travis LB, Hill DA, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Wiklund T, Lynch CF, Van't Veer MB, Glimelius I, Storm H, Pukkala E, Stovall M, Curtis R, Boice JD Jr, Gilbert E: Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA. 2003, 290: 465-75. 10.1001/jama.290.4.465CrossRefPubMed
2.
go back to reference Lynch HT, Lynch JF: What the physician needs to know about Lynch syndrome: an update. Oncology. 2005, 19: 455-63.PubMed Lynch HT, Lynch JF: What the physician needs to know about Lynch syndrome: an update. Oncology. 2005, 19: 455-63.PubMed
3.
go back to reference National Cancer Institute of Canada: Canadian Cancer Statistics 2006Toronto; NCIC; 2006. National Cancer Institute of Canada: Canadian Cancer Statistics 2006Toronto; NCIC; 2006.
4.
go back to reference Ahsan H, Insel BJ, Neugut AI: Risk estimates for second primary cancers. In Multiple Primary Cancers Edited by: Neugut AI, Meadows AT, Robinson E. Philadelphia: Lippincott, Williams & Wilkins; 1999:27-54. Ahsan H, Insel BJ, Neugut AI: Risk estimates for second primary cancers. In Multiple Primary Cancers Edited by: Neugut AI, Meadows AT, Robinson E. Philadelphia: Lippincott, Williams & Wilkins; 1999:27-54.
5.
go back to reference Dong C, Hemminki K: Second primary neoplasms in 633, 964 cancer patients in Sweden, 1958–1996. Int J Cancer. 2001, 93: 155-61. 10.1002/ijc.1317CrossRefPubMed Dong C, Hemminki K: Second primary neoplasms in 633, 964 cancer patients in Sweden, 1958–1996. Int J Cancer. 2001, 93: 155-61. 10.1002/ijc.1317CrossRefPubMed
6.
go back to reference Hammal DM, Bell CL, Craft AW, Parker L: Second primary tumors in children and young adults in the North of England (1968–99). Pediatr Blood Cancer. 2005, 45: 155-61. 10.1002/pbc.20448CrossRefPubMed Hammal DM, Bell CL, Craft AW, Parker L: Second primary tumors in children and young adults in the North of England (1968–99). Pediatr Blood Cancer. 2005, 45: 155-61. 10.1002/pbc.20448CrossRefPubMed
7.
go back to reference Heard A, Roder D, Luke C: Multiple primary cancers of separate organ sites: implications for research and control (Australia). Cancer Causes Control. 2005, 16: 475-81. 10.1007/s10552-004-8023-0CrossRefPubMed Heard A, Roder D, Luke C: Multiple primary cancers of separate organ sites: implications for research and control (Australia). Cancer Causes Control. 2005, 16: 475-81. 10.1007/s10552-004-8023-0CrossRefPubMed
8.
go back to reference Travis LB, Hill DA, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Pukkala E, Lynch CF, Pee D, Smith SA, Van't Veer MB, Joensuu T, Storm H, Stovall M, Boice JD Jr, Gilbert E, Gail MH: Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst. 2005, 97: 1428-37.CrossRefPubMed Travis LB, Hill DA, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Pukkala E, Lynch CF, Pee D, Smith SA, Van't Veer MB, Joensuu T, Storm H, Stovall M, Boice JD Jr, Gilbert E, Gail MH: Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst. 2005, 97: 1428-37.CrossRefPubMed
9.
go back to reference Travis LB, Rabkin CS, Brown LM, Allan JM, Alter BP, Ambrosone CB, Begg CB, Caporaso N, Chanock S, DiMichele A, Figg WD, Gospodarowicz MK, Hall EJ, Hisada M, Inskip P, Kleinerman R, Little JB, Malkin D, Ng AK, Offit K, Pui CH, Robison LL, Rothman N, Shields PG, Strong L, Taniguchi T, Tucker MA, Greene MH: Cancer survivorship – genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst. 2006, 98: 15-25.CrossRefPubMed Travis LB, Rabkin CS, Brown LM, Allan JM, Alter BP, Ambrosone CB, Begg CB, Caporaso N, Chanock S, DiMichele A, Figg WD, Gospodarowicz MK, Hall EJ, Hisada M, Inskip P, Kleinerman R, Little JB, Malkin D, Ng AK, Offit K, Pui CH, Robison LL, Rothman N, Shields PG, Strong L, Taniguchi T, Tucker MA, Greene MH: Cancer survivorship – genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst. 2006, 98: 15-25.CrossRefPubMed
10.
go back to reference Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB: Cancer Incidence in Five Continents Volume VIII. Lyon: International Agency for Research on Cancer; 2002. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB: Cancer Incidence in Five Continents Volume VIII. Lyon: International Agency for Research on Cancer; 2002.
11.
go back to reference Fritz A, Percy C, Jack A, Sobin LH, Parkin MD: International Classification of Diseases for Oncology 3rd edition. Geneva: World Health Organization; 2000. Fritz A, Percy C, Jack A, Sobin LH, Parkin MD: International Classification of Diseases for Oncology 3rd edition. Geneva: World Health Organization; 2000.
12.
go back to reference Adami J, Frisch M, Yuen J, Glimelius B, Melby M: Evidence of an association between non-Hodgkin's lymphoma and skin cancer. Br J Med. 1995, 310: 1491-5.CrossRef Adami J, Frisch M, Yuen J, Glimelius B, Melby M: Evidence of an association between non-Hodgkin's lymphoma and skin cancer. Br J Med. 1995, 310: 1491-5.CrossRef
13.
go back to reference McKenna DB, Stockton D, Brewster DH, Doherty VR: Evidence of an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland. Br J Cancer. 2003, 88: 74-8. 10.1038/sj.bjc.6600692PubMedCentralCrossRefPubMed McKenna DB, Stockton D, Brewster DH, Doherty VR: Evidence of an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland. Br J Cancer. 2003, 88: 74-8. 10.1038/sj.bjc.6600692PubMedCentralCrossRefPubMed
14.
go back to reference Levi F, La Vecchia C, Randimbison L, Te V-C, Erler G: Incidence of invasive cancers following cutaneous malignant melanoma. Int J Cancer. 1997, 72: 776-9. 10.1002/(SICI)1097-0215(19970904)72:5<776::AID-IJC12>3.0.CO;2-7CrossRefPubMed Levi F, La Vecchia C, Randimbison L, Te V-C, Erler G: Incidence of invasive cancers following cutaneous malignant melanoma. Int J Cancer. 1997, 72: 776-9. 10.1002/(SICI)1097-0215(19970904)72:5<776::AID-IJC12>3.0.CO;2-7CrossRefPubMed
15.
go back to reference Bhatti S, Estrada-Batres L, Maryon T, Bogue M, Chu D: Second primary tumors in patients with cutaneous malignant melanoma. Cancer. 1999, 86: 2014-20. 10.1002/(SICI)1097-0142(19991115)86:10<2014::AID-CNCR19>3.0.CO;2-4CrossRef Bhatti S, Estrada-Batres L, Maryon T, Bogue M, Chu D: Second primary tumors in patients with cutaneous malignant melanoma. Cancer. 1999, 86: 2014-20. 10.1002/(SICI)1097-0142(19991115)86:10<2014::AID-CNCR19>3.0.CO;2-4CrossRef
16.
go back to reference Schmid-Wendtner M-H, Baumert J, Wendtner C-M, Plewig G, Volkenandt M: Risk of second primary malignancies in patients with cutaneous melanoma. Br J Derm. 2001, 145: 981-5. 10.1046/j.1365-2133.2001.04507.x. 10.1046/j.1365-2133.2001.04507.xCrossRef Schmid-Wendtner M-H, Baumert J, Wendtner C-M, Plewig G, Volkenandt M: Risk of second primary malignancies in patients with cutaneous melanoma. Br J Derm. 2001, 145: 981-5. 10.1046/j.1365-2133.2001.04507.x. 10.1046/j.1365-2133.2001.04507.xCrossRef
17.
go back to reference Crocetti E, Carli P: Risk of second primary cancers, other than melanoma, in an Italian population-bases cohort of cutaneous malignant melanoma patients. Eur J Cancer Prev. 2004, 13: 33-7. 10.1097/00008469-200402000-00006CrossRefPubMed Crocetti E, Carli P: Risk of second primary cancers, other than melanoma, in an Italian population-bases cohort of cutaneous malignant melanoma patients. Eur J Cancer Prev. 2004, 13: 33-7. 10.1097/00008469-200402000-00006CrossRefPubMed
18.
go back to reference Swerdlow AJ, Storm HH, Sasieni PD: Risks of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943–1989. Int J Cancer. 1995, 61: 773-9.CrossRefPubMed Swerdlow AJ, Storm HH, Sasieni PD: Risks of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943–1989. Int J Cancer. 1995, 61: 773-9.CrossRefPubMed
21.
go back to reference Bajdik CD, Kuo B, Rusaw S, Jones S, Brooks-Wilson A: CGMIM: automated text-mining of Online Mendelian Inheritance in Man (OMIM) to identify genetically-associated cancers and candidate genes. BMC Bioinformatics. 2005, 6: 78. 10.1186/1471-2105-6-78PubMedCentralCrossRefPubMed Bajdik CD, Kuo B, Rusaw S, Jones S, Brooks-Wilson A: CGMIM: automated text-mining of Online Mendelian Inheritance in Man (OMIM) to identify genetically-associated cancers and candidate genes. BMC Bioinformatics. 2005, 6: 78. 10.1186/1471-2105-6-78PubMedCentralCrossRefPubMed
22.
go back to reference Gruber SB, Armstrong BK: Cutaneous and ocular melanoma. In Cancer Epidemiology and Prevention 3rd edition. Edited by: Schottenfeld D, Fraumeni JF Jr. New York: Oxford University Press; 2006:1196-229.CrossRef Gruber SB, Armstrong BK: Cutaneous and ocular melanoma. In Cancer Epidemiology and Prevention 3rd edition. Edited by: Schottenfeld D, Fraumeni JF Jr. New York: Oxford University Press; 2006:1196-229.CrossRef
23.
go back to reference Siemiatycki J, Richardson L, Boffetta P: Occupation. In Cancer Epidemiology and Prevention 3rd edition. Edited by: Schottenfeld D, Fraumeni JF Jr. New York: Oxford University Press; 2006:322-54.CrossRef Siemiatycki J, Richardson L, Boffetta P: Occupation. In Cancer Epidemiology and Prevention 3rd edition. Edited by: Schottenfeld D, Fraumeni JF Jr. New York: Oxford University Press; 2006:322-54.CrossRef
24.
go back to reference Begg CB, Zhang Z, Sun M, Herr HW, Schantz SP: Methodology for evaluating the incidence of second primary cancers with application to smoking related cancers from the Surveillance, Epidemiology, and End Results (SEER) program. Am J Epidemiol. 1995, 142: 653-65.PubMed Begg CB, Zhang Z, Sun M, Herr HW, Schantz SP: Methodology for evaluating the incidence of second primary cancers with application to smoking related cancers from the Surveillance, Epidemiology, and End Results (SEER) program. Am J Epidemiol. 1995, 142: 653-65.PubMed
Metadata
Title
Identifying related cancer types based on their incidence among people with multiple cancers
Authors
Chris D Bajdik
Zenaida U Abanto
John J Spinelli
Angela Brooks-Wilson
Richard P Gallagher
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Emerging Themes in Epidemiology / Issue 1/2006
Electronic ISSN: 1742-7622
DOI
https://doi.org/10.1186/1742-7622-3-17

Other articles of this Issue 1/2006

Emerging Themes in Epidemiology 1/2006 Go to the issue